| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-12 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-06 |